No of AMD patients to reach 1.7 mn by 2030 in Aus

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 06 May, 2013

Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million by 2030, yet many patients do not currently receive timely care. Th...Read more

Bionomics cancer trial shows +ve results

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its cancer drug candidate BNC105 in women with ovarian cancer. After com...Read more

Melanoma study reaches efficacy milestone

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

Singapore: Australia-based Viralytics in its ongoing US-based phase II melanoma trial of its virotherapy candidate Cavatak achieved an interim efficacy milestone of three Objective Respons...Read more

NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

Medigene, SynCore expand deal for Veregen

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and supply contract into new re...Read more

Kane Biotech issued patent in Australia for Aledex

Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

Singapore: Canada-based Kane Biotech, which is engaged in the development and commercialization of products that prevent and remove microbial biofilms, has been granted a patent by the Aust...Read more

Aus, NZ progress on joint regulatory agency

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic Products Agency (ANZTPA) implementation ministerial council in a con...Read more

Aerocrine receives Australian TGA approval

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

Singapore: Aerocrine received marketing approval for its airway inflammation monitor, NIOX MINO and NIOX MINO Test Kit, in the Australian market. The decision to grant the marketing approva...Read more

Lipitor leads in Australia

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

Innova, TGR to co-market ELISA technology

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

Singapore: Australia-based, TGR BioSciences, a life sciences company focused on the development of rapid, high sensitivity ELISA systems using their CaptSure technology, and UK-based Innova...Read more

Alchemia appoints new chairman

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-executive Chairman of the Board of Directors, effective as of 1 March 20...Read more

Bionomics, Merck Serono end agreement

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended their agreement to jointly develop new treatments for MS and other aut...Read more

AstraZeneca, Alchemia sign $240 mn drug deal

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

Victoria court approves Biota's merger with Nabi Biopharma

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders of its ordinary shares that will result in the merger of Biota and Nab...Read more

Eisai gets approval for Halaven in Australia

Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Department of Health and Aging to market its anticancer agent Halaven (eribul...Read more

GI Dynamics starts US trial of EndoBarrier

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the treatment of patients, who have uncontrolled type 2 diabetes and are ...Read more

Pharmaxis for Prix Galien UK award

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan Drug Award, that covers innovations in pharmaceutical R&D. Austral...Read more

Genome of extinct frog revived for fresh egg

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

Singapore: The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophisticated cloning technology to implant a "dead" cell nucleus into a f...Read more